|Binx Health Inc., of Boston,||Binx Io||Molecular point-of-care testing platform||Detection of chlamydia and gonorrhea in vaginal swab and male urine specimens||Received expanded 510(k) clearance from the U.S. FDA for detection in male urine specimens|
|Cerus Endovascular Ltd., of Fremont, Calif.||021 Contour Neurovascular System||A fine mesh braid that is deployed across the neck of the aneurysm sac||Treatment of saccular intracranial aneurysms||Received CE mark approval|
|Nines Inc., of Palo Alto, Calif.||NinesAI||Artificial intelligence (AI)-based software||Supports the automated radiological review of CT head images for the possible presence intracranial hemorrhage and mass effect to aid radiologists in triaging case||Received U.S. FDA clearance|
|Refine USA LLC, of Jacksonville, Fla.||Rejuvapen Nxt||Microneedling device||For wrinkle reduction and aesthetic use||Received 510(k) clearance from the U.S. FDA|
|Rheonix Inc., of Ithaca, N.Y.||Rheonix COVID-19 MDx Assay||Automated RT-PCR assay for the Rheonix Encompass MDx workstation; provides same-day test results||For the qualitative detection of nucleic acid from SARS-CoV-2 in respiratory samples||Received emergency use authorization from the U.S. FDA|
|Synaptive Medical Inc., of Toronto||Evry||Superconducting, head magnetic resonance imaging technology||For diagnostic imaging at the point of care in critical care settings||Received U.S. FDA clearance|
For more information about individual companies and/or products, see Cortellis.